Literature DB >> 8561042

Efficacy of high dose amino acid solution on spinal cord injury induced by focal Nd:YAG laser irradiation.

A Colak1, G Nurlu, B Açikgöz, O E Ozcan.   

Abstract

In this experimental study, a neodymium:yttrium-aluminium-garnet (Nd:YAG) laser was used to induce highly reproducible focal spinal cord lesions in anaesthetized guinea pigs. The efficacy of high dose amino acid solution (HDAAS) on this injury is investigated. Experiments were performed on 36 animals divided into three groups; sham operated controls, laser irradiated surgical controls, and amino acid groups. Acute responses to injury were evaluated with somatosensory (SSEP) and motor evoked potentials (MEP) and functional recovery was assessed for 8 weeks using the inclined plane technique. In the laser irradiated surgical control group, MEP disappeared one hour after the laser injury, but SSEP revealed changes of amplitude and latency. In this group, the average value of the inclined plane at 24 hours after the laser application was 45.3 +/- 1.4 degrees. In the amino acid group, at the sixth hour of injury, MEP and SSEP changes improved with infusion of HDAAS for 4 hours. This improvement was statistically significant (for latency of SSEP U = 140 p < 0.05). Inclined plane value at 24 hours after the laser application was 65.5 +/- 1.2 degrees in this group. This study showed that application of Nd:YAG laser irradiation on the spinal cord induced spinal cord injury which presented as paraparesis, HDAAS may provide significant therapeutic protection in secondary damage following this injury and may have a potential role in the treatment of acute spinal cord injury.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8561042     DOI: 10.1007/bf01404952

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  34 in total

1.  The toxic effect of sodium L-glutamate on the inner layers of the retina.

Authors:  D R LUCAS; J P NEWHOUSE
Journal:  AMA Arch Ophthalmol       Date:  1957-08

2.  Objective clinical assessment of motor function after experimental spinal cord injury in the rat.

Authors:  A S Rivlin; C H Tator
Journal:  J Neurosurg       Date:  1977-10       Impact factor: 5.115

Review 3.  Glutamate and the pathophysiology of hypoxic--ischemic brain damage.

Authors:  S M Rothman; J W Olney
Journal:  Ann Neurol       Date:  1986-02       Impact factor: 10.422

4.  Branched chain metabolic support. A prospective, randomized, double-blind trial in surgical stress.

Authors:  F B Cerra; J E Mazuski; E Chute; N Nuwer; K Teasley; J Lysne; E P Shronts; F N Konstantinides
Journal:  Ann Surg       Date:  1984-03       Impact factor: 12.969

5.  Effect of acute spinal cord compression injury on regional spinal cord blood flow in primates.

Authors:  A N Sandler; C H Tator
Journal:  J Neurosurg       Date:  1976-12       Impact factor: 5.115

6.  Hyperemia, CO2 responsiveness, and autoregulation in the white matter following experimental spinal cord injury.

Authors:  A J Smith; D B McCreery; J R Bloedel; S N Chou
Journal:  J Neurosurg       Date:  1978-02       Impact factor: 5.115

7.  Platelet-activating factor and progressive brain damage following focal brain injury.

Authors:  K U Frerichs; P J Lindsberg; J M Hallenbeck; G Z Feuerstein
Journal:  J Neurosurg       Date:  1990-08       Impact factor: 5.115

8.  Time course and spatial distribution of neodymium: yttrium-aluminum-garnet (Nd:YAG) laser-induced lesions in the rat brain.

Authors:  H R Eggert; M Kiessling; P Kleihues
Journal:  Neurosurgery       Date:  1985-04       Impact factor: 4.654

9.  Phospholipid degradation and edema development in cold-injured rat brain.

Authors:  P H Chan; S Longar; R A Fishman
Journal:  Brain Res       Date:  1983-10-31       Impact factor: 3.252

10.  Branched chains support postoperative protein synthesis.

Authors:  F B Cerra; D Upson; R Angelico; C Wiles; J Lyons; L Faulkenbach; J Paysinger
Journal:  Surgery       Date:  1982-08       Impact factor: 3.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.